The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: A pilot study

Tunca M., Tankurt E., Akpinar H., Akar S., Hizli N., Gonen O.

BRITISH JOURNAL OF RHEUMATOLOGY, vol.36, no.9, pp.1005-1008, 1997 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 9
  • Publication Date: 1997
  • Doi Number: 10.1093/rheumatology/36.9.1005
  • Journal Name: BRITISH JOURNAL OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1005-1008
  • Keywords: familial Mediterranean fever, interferon alpha, TUMOR-NECROSIS-FACTOR, INFLAMMATORY ATTACKS, PROPOSED MECHANISM, AMYLOIDOSIS, THERAPY
  • Dokuz Eylül University Affiliated: No

Abstract

About a quarter of familial Mediterranean fever (FMF) patients have recurrent painful attacks of polyserositis despite regular colchicine treatment. There is no known alternative drug for colchicine-resistant cases. We had previously observed a patient with FMF whose painful attacks disappeared during the 6 month period of interferon alpha (IFN) treatment for his chronic hepatitis B. The objective of the present study was to investigate the possible beneficial effect of IFN on these episodes. Twenty-one consecutive attacks in seven adult patients with FMF were treated at early onset with IFN, the dosage being 3-10 million IU s.c. Eighteen of the 21 attacks could be halted in a mean time of 3.05 h, while the intensity of abdominal pain remained very low. Observed side-effects were generally mild and acceptable. IFN may be a useful adjunct for the treatment of colchicine-resistant attacks in FMF patients.